Articles From: PetSmart Exploring Strategic Alternatives to Maximize Shareholder Value to PFSweb to Present at the 2014 Gateway Conference on September 4


PetSmart, Inc .
Sign-up for PetSmart Exploring Strategic Alternatives to Maximize Shareholder Value investment picks
2014/9/8
PetSmart’s 53,000 associates across the United States, Canada and Puerto Rico are working together this week to give back during the company’s first-ever enterprise-wide week of volunteering.
Sign-up for PetSmart Launches CommUNITY Week Across North America investment picks
2014/8/19
Sign-up for PetSmart reports higher profit, sales investment picks
By Anna Prior PetSmart Inc. said its board has been reviewing potential changes to the pet-supply retailer's capital structure, including returning capital to shareholders, amid activist pressure.
Sign-up for PetSmart reviews capital structure amid activist pressure investment picks
2014/8/25
PetSmart, Inc. has partnered with the City of Sacramento to bring a portable, pop-up dog park to Sacramento.
Sign-up for PetSmart Unleashes Its One-of-a-Kind Pop-Up Park (P.U.P.) in Sacramento investment picks
PetSmart, Inc. (NASDAQ: PETM ) will release its results for the second quarter 2014 before market open on Wednesday, August 20, 2014.
Sign-up for PetSmart, Inc. to Host Second Quarter 2014 Earnings Conference Call investment picks
THE WOODLANDS, Texas , July 3, 2014 /PRNewswire/ -- CB&I (NYSE:CBI) today announced Lasse Petterson , who announced his retirement in December 2013 as Executive Vice President and Chief Operating Officer, has fulfilled his remaining obligations to the Company effective June 5, 2014 .
Sign-up for Petterson Retirement investment picks
2014/7/30
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Earnings reports were high on the agenda in Europe on Wednesday, moving shares of prominent companies such as Peugeot SA, Airbus Group NV and Barclays PLC.
Sign-up for Peugeot, Barclays among major European movers after earnings investment picks
2014/7/29
SAN DIEGO , July 29, 2014 /PRNewswire/ -- Pfenex Inc. (NYSE MKT: PFNX) today announced that it has closed its previously announced initial public offering of 8,333,333 shares of its common stock at a price to the public of $6.00 per share.
Sign-up for Pfenex Announces Closing of Initial Public Offering investment picks
2014/8/29
SAN DIEGO , Aug.
Sign-up for Pfenex Reports Second Quarter 2014 Results and Provides Business Update investment picks
Pfizer Inc. (NYSE:PFE) and Cellectis (Paris:ALCLS) today announced that they have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select targets.
Sign-up for Pfizer And Cellectis Enter Into Global Strategic Cancer Immunotherapy Collaboration investment picks
Pfizer Inc. (NYSE:PFE) and Merck & Co.
Sign-up for Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen investment picks
Pfizer Inc. (NYSE:PFE) and Protalix BioTherapeutics, Inc. (NYSE-MKT:PLX, TASE:PLX) announced today that the U.S. Food and Drug Administration (FDA) approved ELELYSO™ (taliglucerase alfa) for injection for pediatric patients.
Sign-up for Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease investment picks
Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for bivalent recombinant LP2086 (rLP2086), the company’s vaccine candidate for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in 10 through 25 year olds.
Sign-up for Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine investment picks
Pfizer Inc. (NYSE:PFE) today announced the positive results of a Phase 3 study comparing a prophylaxis regimen of BeneFIX ® Coagulation Factor IX (Recombinant) 100 IU/kg once-weekly to on-demand treatment in people with moderately severe to severe hemophilia B.
Sign-up for Pfizer Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA (BeneFIX®) Once-Weekly Prophylaxis For Hemophilia B investment picks
Pfizer Inc. (NYSE:PFE) announced today that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for bivalent recombinant LP2086 (rLP2086), the company’s vaccine candidate for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in 10 to 25 year olds.
Sign-up for Pfizer Announces Submission of Biologics License Application to the FDA for Investigational Meningococcal B Vaccine investment picks
Pfizer Inc. today announced it has completed the submission of a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for palbociclib.
Sign-up for Pfizer Announces Submission of Palbociclib New Drug Application to the FDA investment picks
2014/6/26
The board of directors of Pfizer Inc. today declared a 26-cent third-quarter 2014 dividend on the company’s common stock, payable September 3, 2014, to shareholders of record at the close of business on August 1, 2014.
Sign-up for Pfizer Declares 26-Cent Third-Quarter 2014 Dividend investment picks
2014/7/30
Pfizer Inc. today announced that it has entered into a definitive agreement to acquire Baxter International Inc.’s portfolio of marketed vaccines for $635 million.
Sign-up for Pfizer Enters Into Agreement to Acquire Baxter’s Portfolio of Marketed Vaccines investment picks
2014/9/3
Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Geno Germano, Group President, Global Innovative Pharma Business, at the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2014 at 12:55 p.m. Eastern Daylight Time.
Sign-up for Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference investment picks
2014/6/24
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, July 29, 2014.
Sign-up for Pfizer Invites Public to View and Listen to Webcast of July 29 Conference Call with Analysts investment picks
Pfizer Inc. (NYSE:PFE) announced today the opening of a new 280,000 square-foot Research and Development (R&D) hub in Cambridge, Mass.
Sign-up for Pfizer Opens New State-of-the-Art Research and Development Site in Cambridge, Massachusetts investment picks
Pfizer Inc. (NYSE:PFE) reported financial results for second-quarter 2014.
Sign-up for PFIZER REPORTS SECOND-QUARTER 2014 RESULTS investment picks
Pfizer Inc. (NYSE:PFE) announced today top-line results from two placebo-controlled studies conducted in China with Lyrica ® (pregabalin) in patients with postherpetic neuralgia (pain after shingles or PHN) and painful diabetic peripheral neuropathy (pDPN), respectively.
Sign-up for Pfizer Reports Top-line Results from Postherpetic Neuralgia and Painful Diabetic Peripheral Neuropathy Lyrica® Studies Conducted in China investment picks
Pfizer Inc. (NYSE:PFE) and InnoPharma, Inc., a privately held pharmaceutical development company, today announced that they have entered into an agreement under which Pfizer will acquire InnoPharma.
Sign-up for Pfizer to Acquire InnoPharma, Inc. investment picks
By Anna Prior Pfizer Inc. said it has agreed to acquire Baxter International Inc.'s portfolio of marketed vaccines for $635 million.
Sign-up for Pfizer to buy Baxter's vaccines for $635 million investment picks
Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the company’s investigational Clostridium difficile (C. difficile) vaccine candidate ( PF-06425090). Currently in Phase 2 clinical development, the vaccine candidate is designed to prevent C.
Sign-up for Pfizer’s Investigational Vaccine Candidate for Clostridium difficile Receives U.S. Food and Drug Administration Fast Track Designation investment picks
http://media.marketwire.com/attachments/201309/183468_PFSWLogos.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1142096&ProfileId=051205&sourceType=1 ALLEN, TX --
Sign-up for PFSweb Acquires eCommerce System Integrator REV Solutions investment picks
http://media.marketwire.com/attachments/201309/183468_PFSWLogos.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1127562&ProfileId=051205&sourceType=1 ALLEN, TX --
Sign-up for PFSweb Announces Results of 2014 Annual Meeting of Stockholders investment picks
http://media.marketwire.com/attachments/201309/183468_PFSWLogos.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1139231&ProfileId=051205&sourceType=1 ALLEN, TX --
Sign-up for PFSweb to Present at the 2014 Gateway Conference on September 4 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: PetSmart Exploring Strategic Alternatives to Maximize Shareholder Value to PFSweb to Present at the 2014 Gateway Conference on September 4
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices